Hemostatic efficacy of marstacimab alone or in combination with bypassing agents in hemophilia plasmas and a mouse bleeding model

por Pittman, Debra D., Rakhe, Swapnil, Bowley, Sheryl R., Jasuja, Reema, Barakat, Amey, Murphy, John E.
Publicado 2022

Validation of patient‐reported vaso‐occlusive crisis day as an endpoint in sickle cell disease studies

por Coyne, Karin S., Currie, Brooke M., Callaghan, Michael, Wyrwich, Kathleen W., Pease, Sheryl, Baker, Christine L., Arkin, Steven, Pittman, Debra D.
Publicado 2022

PF‐04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo‐Controlled Study

por Charnigo, Robert J., Beidler, David, Rybin, Denis, Pittman, Debra D., Tan, Beesan, Howard, Jo, Michelson, Alan D., Frelinger, Andrew L., Clarke, Nicholas
Publicado 2018

Inhibition of the RAGE products increases survival in experimental models of severe sepsis and systemic infection

por Lutterloh, Emily C, Opal, Steven M, Pittman, Debra D, Keith, James C, Tan, Xiang-Yang, Clancy, Brian M, Palmer, Helen, Milarski, Kim, Sun, Ying, Palardy, John E, Parejo, Nicholas A, Kessimian, Noubar
Publicado 2007

Correction of the coagulation defect in hemophilia using a factor Xa variant with novel engineered protease function

por Ivanciu, Lacramioara, Toso, Raffaella, Margaritis, Paris, Pavani, Giulia, Kim, Haein, Schlachterman, Alexander, Liu, Jian-Hua, Clerin, Valerie, Pittman, Debra D., Rose-Miranda, Rosalind, Shields, Kathleen M., Erbe, David V., Tobin, James F., Arruda, Valder R., Camire, Rodney M.
Publicado 2011